LPL Financial’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-28,420
| Closed | -$117K | – | 4579 |
|
|
2022
Q1 | $117K | Buy |
28,420
+390
| +1% | +$1.42K | ﹤0.01% | 3952 |
|
|
2021
Q4 | $100K | Hold |
28,030
| – | – | ﹤0.01% | 4138 |
|
|
2021
Q3 | $102K | Buy |
28,030
+250
| +0.9% | +$1.01K | ﹤0.01% | 4140 |
|
|
2021
Q2 | $121K | Buy |
27,780
+13,125
| +90% | +$53.5K | ﹤0.01% | 4028 |
|
|
2021
Q1 | $60K | Buy |
+14,655
| New | +$63.5K | ﹤0.01% | 3977 |
|
|
2019
Q3 | – | Sell |
-10,455
| Closed | -$34K | – | 3398 |
|
|
2019
Q2 | $34K | Sell |
10,455
-1,345
| -11% | -$3.89K | ﹤0.01% | 3222 |
|
|
2019
Q1 | $36K | Sell |
11,800
-2,000
| -14% | -$6.48K | ﹤0.01% | 3133 |
|
|
2018
Q4 | $38K | Buy |
13,800
+1,000
| +8% | +$3.29K | ﹤0.01% | 3015 |
|
|
2018
Q3 | $43K | Sell |
12,800
-18,391
| -59% | -$56.8K | ﹤0.01% | 3179 |
|
|
2018
Q2 | $80K | Buy |
31,191
+3,000
| +11% | +$7.46K | ﹤0.01% | 3121 |
|
|
2018
Q1 | $62K | Buy |
28,191
+8,800
| +45% | +$19.8K | ﹤0.01% | 3110 |
|
|
2017
Q4 | $39K | Sell |
19,391
-26,803
| -58% | -$58.3K | ﹤0.01% | 2983 |
|
|
2017
Q3 | $150K | Hold |
46,194
| – | – | ﹤0.01% | 2725 |
|
|
2017
Q2 | $149K | Sell |
46,194
-2,500
| -5% | -$7.09K | ﹤0.01% | 2659 |
|
|
2017
Q1 | $140K | Buy |
48,694
+14,391
| +42% | +$34.6K | ﹤0.01% | 2562 |
|
|
2016
Q4 | $79K | Hold |
34,303
| – | – | ﹤0.01% | 2606 |
|
|
2016
Q3 | $57K | Sell |
34,303
-6,000
| -15% | -$7.35K | ﹤0.01% | 2572 |
|
|
2016
Q2 | $40K | Sell |
40,303
-703
| -2% | -$679 | ﹤0.01% | 2570 |
|
|
2016
Q1 | $35K | Buy |
41,006
+26,006
| +173% | +$25.2K | ﹤0.01% | 3030 |
|
|
2015
Q4 | $18K | Buy |
+15,000
| New | +$20.9K | ﹤0.01% | 3108 |
|
|
2014
Q4 | – | Sell |
-10,810
| Closed | -$21K | – | 2818 |
|
|
2014
Q3 | $21K | Sell |
10,810
-2,000
| -16% | -$4.36K | ﹤0.01% | 2668 |
|
|
2014
Q2 | $34K | Buy |
12,810
+1,000
| +8% | +$3.01K | ﹤0.01% | 2643 |
|
|
2014
Q1 | $41K | Hold |
11,810
| – | – | ﹤0.01% | 2598 |
|
|
2013
Q4 | $53K | Hold |
11,810
| – | – | ﹤0.01% | 2598 |
|
|
2013
Q3 | $55K | Buy |
11,810
+1,000
| +9% | +$4.37K | ﹤0.01% | 2490 |
|
|
2013
Q2 | $45K | Buy |
+10,810
| New | +$41.8K | ﹤0.01% | 2373 |
|
Other funds holding ATRS
LPL Financial's ATRS Position: Q2 2022 in Review
LPL Financial sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 28,420 shares — an estimated $117K sold.
LPL Financial first reported a position in ATRS in Q2 2013 and held it in 26 quarters. The position peaked at $150K in Q3 2017. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- LPL Financial reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- LPL Financial sold 28,420 Antares Pharma, Inc. shares in Q2 2022, an estimated $117K.
- LPL Financial first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 26 quarters.
- LPL Financial's Antares Pharma, Inc. position peaked at $150K in Q3 2017.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on LPL Financial's 13F filing for Q2 2022, filed 12 Aug 2022.